Interleukin inhibitors

Cosentyx 150 mg/mL single-dose Sensoready pen Images

Generic Name: secukinumab

This medication has been identified as Cosentyx 150 mg/mL single-dose Sensoready pen. It is supplied by Novartis Pharmaceuticals Corporation.

Cosentyx is used in the treatment of Ankylosing Spondylitis; Psoriatic Arthritis; Enthesitis-Related Arthritis; Non-Radiographic Axial Spondyloarthritis; Psoriasis and belongs to the drug class interleukin inhibitors. There is no proven risk in humans during pregnancy. Cosentyx 150 mg/mL single-dose Sensoready pen is not a controlled substance under the Controlled Substances Act (CSA).

Images

Cosentyx (Secukinumab [ sek-ue-kin-ue-mab ])-medicine-150 mg/mL single-dose Sensoready pen

Cosentyx
Generic Name: secukinumab [ sek-ue-kin-ue-mab ]
Imprint: medicine
Strength: 150 mg/mL single-dose Sensoready pen
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Interleukin inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00078-0639
Inactive Ingredients:
Latest News
Related Drugs